EACR Goodbye Flat Biology: ex vivo to in vivo models of cancer

This conference will feature talks on mechanobiology, the immune response, how the extracellular matrix controls cell architecture, and how cell fate transitions underpin tissue morphogenesis and the metastatic cascade. The target audience for this conference is scientists, postdocs, and graduate students interested in the latest generation of engineered ex vivo models of tissue biology, in vivo cancer biology, and the use of these mechanobiological concepts for the development of cancer therapeutics. It will also be highly relevant for industry scientists interested in cutting-edge models of cancer and journal editors interested in ex vivo to in vivo models of biology and cancer.

Submit your abstract by 23 June 2025 and register by 26 August 2025 to join us in Essen. EACR Travel Grants are available for this meeting.

Speakers: Frances Balkwill | Thomas H Barker | David Bryant | Emmanuel Donnadieu | Peter Friedl | Johanna Ivaska | Henriëtte Lanz | Michael Milone | Kevin Myant | Matthew Paszek | Marta Shahbazi | Samantha Stehbens | Chris Tape | Viola Vogel | Valerie Weaver | Sara Wickstrom

Keywords: cancer research, oncology, in vitro models of cancer, ex vivo models of cancer, in vivo models of cancer, the extracellular matrix, cancer cell architecture, mechanobiology, immune response to cancer, tissue morphogenesis, the metastatic cascade, cancer immunotherapies, advanced imaging technologies, organoids, microtissue platforms, spatial transcriptomics, cell fate transitions, homeostasis, cancer progression, cancer therapeutic developments.

Deadlines:

Travel grant application deadline: 23 June 2025

Abstract submission deadline: 23 June 2025

Registration deadline: 26 August 2025